Analysts’ Viewpoint
Increase in prevalence of neurological disorders, advancements in technology, and surge in healthcare awareness are the key factors driving the neurology diagnostic and monitoring devices market size.
EEG systems, MRI systems, and CT scanners are expected to witness high demand due to the aging population and better awareness about neurological disorders.
The market is currently dominated by North America and Europe, but Asia Pacific is expected to witness significant growth in the coming years due to rise in awareness and healthcare expenditure.
Development of advanced diagnostic and monitoring equipment, such as MRI & fMRI, digital sensors, and wearable technology, has further fueled market growth.
The global neurology diagnostic and monitoring devices market is poised for significant growth in the next few years, driven by continuous technological advancements.
Neurodegenerative diseases, epilepsy, and stroke affect millions of people worldwide and require accurate and timely diagnosis for effective management and treatment.
Key devices used in diagnosis and monitoring include electroencephalogram (EEG) systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) scanners, position emission tomography (PET) systems, and ultrasound imaging systems.
The rise in prevalence of neurodegenerative diseases, along with the aging population, contribute to the demand for these devices. Technological advancements, such as portable and wireless devices, make neurology diagnostics and monitoring more accessible and convenient.
Advancements in neuroimaging and diagnostic tools are offering lucrative opportunities for neurology diagnostic and monitoring devices market expansion. Devices such as EEG systems, MRI systems, CT scanners, PET systems, and ultrasound imaging systems enable healthcare professionals to accurately diagnose and monitor various neurological conditions.
Real-time diagnostic data collection through wearable technology and digital sensors has improved the accuracy and speed of diagnosis for neurodegenerative diseases. Whole-exome sequencing in clinical diagnostics has enabled more personalized treatment plans for complex neurologic diagnoses.
MRI technology advancements, particularly fMRI and high-resolution imaging, have improved understanding of central nervous system pathologies, facilitating targeted treatments for conditions including epilepsy and stroke.
Furthermore, the demand for non-invasive, accurate diagnostic tools contributes to neurology diagnostic and monitoring devices market growth. Integration of new technologies is expected to continue, improving patient outcomes and driving neurology advancements.
Governments around the world have taken up initiatives to improve neurological care, leading to an increase in funding for research and development in this field. As neurological disorders continue to rise globally, there has been a growing demand for accurate and efficient diagnostic and monitoring devices.
This demand is further fueled by the increase in awareness about the importance of early detection and management of neurological disorders.
This has resulted in the development of advanced and innovative devices, such as brain imaging technologies, electroencephalography (EEG) machines, and neuromodulation devices. The combination of increasing healthcare expenditure and government initiatives, along with the development of advanced and innovative devices, has been a major driving force boosting the neurology diagnostic and monitoring devices market value.
Constant advancements in technology have resulted in the development and availability of advanced diagnostic and monitoring equipment for neurological disorders.
Magnetic Resonance Imaging (MRI), Functional MRI (fMRI), digital sensors and wearable technology, whole-exome sequencing, AI-driven platforms, and neurovative diagnostics are just some of the innovative tools that are being used in the diagnosis and monitoring of neurological disorders.
These technologies offer improved accuracy, sensitivity, and real-time data collection, aiding in the early detection and intervention of neurological diseases. Moreover, the development of smart clothing and artificial intelligence-based tools has further expanded the capabilities of neurology diagnostic and monitoring devices, making them more accessible and convenient for patients.
The involvement of private organizations, public entities, and institutions in the development of these technologies has also contributed to their widespread adoption. As a result, the demand for these advanced devices is expected to continue to rise, augmenting the neurology diagnostic and monitoring devices market revenue.
Based on device type, the computed tomography (CT) scanner segment dominated the neurology diagnostic and monitoring devices industry in 2022. Technological advancements, increasing patient focus on early disease diagnosis, and a rising incidence of targeted diseases are responsible for the dominance of this segment.
The growing preference for minimally invasive diagnostic procedures and the procedural benefits offered by CT scanners further propels the segment.
The neurology diagnostic and monitoring devices market segmentation based on indication includes neurodegenerative disease, epilepsy, stroke, and others. Growth of the market is closely tied to the increasing prevalence of neurodegenerative diseases.
According to research, the neurodegenerative disease segment dominated the global market in 2022.
This is largely due to the millions of people worldwide being affected by these diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. With such a significant concern, there is a growing need for effective diagnostic and monitoring devices to aid in early detection and management of these diseases.
Non-communicable neurological disorders, such as migraines, multiple sclerosis, Alzheimer's, Parkinson's, and epilepsy, are becoming a global public health challenge. The burden of these disorders is set to rise due to aging populations.
Based on end-user, the hospitals and surgery centers segment is dominant as these facilities conduct thorough evaluations and consider factors such as clinical efficacy, cost-effectiveness, and long-term benefits to ensure the selection of devices that meet their specific needs and offer the best value for money.
They are often affiliated with healthcare organizations that prioritize quality and patient outcomes, emphasizing the importance of selecting the right devices.
The presence of HTA governance models in these centers adds another layer of scrutiny to the purchasing process, assessing the overall impact of a medical device on patient outcomes, healthcare costs, and resource utilization.
As per the latest neurology diagnostic and monitoring devices market forecast, North America dominated the global industry in 2022. Technological advancements, increasing awareness of neurological disorders, high purchasing power, and presence of key players are driving market dynamics in the region.
The rising incidence of neurological disorders in North America has also increased demand for neurology monitoring devices.
Technological advancements in the field attributed to companies such as GE Healthcare, Neurosoft, and Canon Medical Systems Corporation (Canon, Inc.) have contributed to the growth of the neurology diagnostic and monitoring devices market in North America.
Leading players in the global neurology diagnostic and monitoring devices market have adopted strategies such as product portfolio expansion, and securing funding for product development in order to increase market share.
As per the neurology diagnostic and monitoring devices market analysis, the landscape is highly competitive with the strong presence of key players.
GE Healthcare, Neurosoft, Canon Medical Systems Corporation (Canon, Inc.), Fujifilm Holding Corporation, Koninklijke Philips N.V., Siemens Healthineers AG, Shimadzu Corporation, United Imaging Healthcare Co., Ltd. Hologic, Inc., and Esaote SpA are the prominent neurology diagnostic and monitoring devices manufacturers.
Key players have been profiled in the global neurology diagnostic and monitoring devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 | US$ 6.5 Bn |
| Forecast (Value) in 2031 | US$ 12.4 Bn |
| Growth Rate (CAGR) | 7.5% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 6.5 Bn in 2022
It is projected to reach more than US$ 12.4 Bn by the end of 2031
The CAGR is projected to be 7.5% from 2023 to 2031
Improvements in neuroimaging and diagnostic tools, and surge in adoption of new technologies
North America is projected to account for major share during the forecast period
GE Healthcare, Neurosoft, Canon Medical Systems Corporation (Canon, Inc.), Fujifilm Holding Corporation, Koninklijke Philips N.V., Siemens Healthineers AG, Shimadzu Corporation, United Imaging Healthcare Co., Ltd. Hologic, Inc., and Esaote SpA.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neurology Diagnostic and Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, 2017 - 2031
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
5.2. Key Vendor and Distributor Analysis
5.3. Evolving Trends in Medical Imaging Services
5.4. Winning Imperatives, by Key Players
5.5. Growing Adoption of Remote Monitoring Technology, by Medical Imaging Service Providers
5.6. Technological Advancements
6. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Device Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Device Type, 2017 - 2031
6.3.1. Electroencephalogram (EEG) Systems
6.3.2. Magnetic Resonance Imaging (MRI) Systems
6.3.3. Computed Tomography (CT) Scanner
6.3.4. Position emission tomography (PET) System
6.3.5. Ultrasound Imaging Systems
6.3.6. Others
6.4. Market Attractiveness By Device Type
7. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication, 2017 - 2031
7.3.1. Neurodegenerative Disease
7.3.2. Epilepsy
7.3.3. Stroke
7.3.4. Others
7.4. Market Attractiveness By Indication
8. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017 - 2031
8.3.1. Hospitals and Surgery Centers
8.3.2. Neurology Centers
8.3.3. Ambulatory Care Centers
8.3.4. Diagnostic Laboratories & Imaging Centers
8.3.5. Research Laboratories & Academic Institutes
8.4. Market Attractiveness By End-user
9. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Device Type, 2017 - 2031
10.2.1. Electroencephalogram (EEG) Systems
10.2.2. Magnetic Resonance Imaging (MRI) Systems
10.2.3. Computed Tomography (CT) Scanner
10.2.4. Position emission tomography (PET) System
10.2.5. Ultrasound Imaging Systems
10.2.6. Others
10.3. Market Value Forecast By Indication, 2017 - 2031
10.3.1. Neurodegenerative Disease
10.3.2. Epilepsy
10.3.3. Stroke
10.3.4. Others
10.4. Market Value Forecast By End-user, 2017 - 2031
10.4.1. Hospitals and Surgery Centers
10.4.2. Neurology Centers
10.4.3. Ambulatory Care Centers
10.4.4. Diagnostic Laboratories & Imaging Centers
10.4.5. Research Laboratories & Academic Institutes
10.5. Market Value Forecast By Country, 2017 - 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Device Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Device Type, 2017 - 2031
11.2.1. Electroencephalogram (EEG) Systems
11.2.2. Magnetic Resonance Imaging (MRI) Systems
11.2.3. Computed Tomography (CT) Scanner
11.2.4. Position emission tomography (PET) System
11.2.5. Ultrasound Imaging Systems
11.2.6. Others
11.3. Market Value Forecast By Indication, 2017 - 2031
11.3.1. Neurodegenerative Disease
11.3.2. Epilepsy
11.3.3. Stroke
11.3.4. Others
11.4. Market Value Forecast By End-user, 2017 - 2031
11.4.1. Hospitals and Surgery Centers
11.4.2. Neurology Centers
11.4.3. Ambulatory Care Centers
11.4.4. Diagnostic Laboratories & Imaging Centers
11.4.5. Research Laboratories & Academic Institutes
11.5. Market Value Forecast By Country, 2017 - 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Device Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Device Type, 2017 - 2031
12.2.1. Electroencephalogram (EEG) Systems
12.2.2. Magnetic Resonance Imaging (MRI) Systems
12.2.3. Computed Tomography (CT) Scanner
12.2.4. Position emission tomography (PET) System
12.2.5. Ultrasound Imaging Systems
12.2.6. Others
12.3. Market Value Forecast By Indication, 2017 - 2031
12.3.1. Neurodegenerative Disease
12.3.2. Epilepsy
12.3.3. Stroke
12.3.4. Others
12.4. Market Value Forecast By End-user, 2017 - 2031
12.4.1. Hospitals and Surgery Centers
12.4.2. Neurology Centers
12.4.3. Ambulatory Care Centers
12.4.4. Diagnostic Laboratories & Imaging Centers
12.4.5. Research Laboratories & Academic Institutes
12.5. Market Value Forecast By Country, 2017 - 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Device Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country
13. Latin America Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Device Type, 2017 - 2031
13.2.1. Electroencephalogram (EEG) Systems
13.2.2. Magnetic Resonance Imaging (MRI) Systems
13.2.3. Computed Tomography (CT) Scanner
13.2.4. Position emission tomography (PET) System
13.2.5. Ultrasound Imaging Systems
13.2.6. Others
13.3. Market Value Forecast By Indication, 2017 - 2031
13.3.1. Neurodegenerative Disease
13.3.2. Epilepsy
13.3.3. Stroke
13.3.4. Others
13.4. Market Value Forecast By End-user, 2017 - 2031
13.4.1. Hospitals and Surgery Centers
13.4.2. Neurology Centers
13.4.3. Ambulatory Care Centers
13.4.4. Diagnostic Laboratories & Imaging Centers
13.4.5. Research Laboratories & Academic Institutes
13.5. Market Value Forecast By Country, 2017 - 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Device Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Device Type, 2017 - 2031
14.2.1. Electroencephalogram (EEG) Systems
14.2.2. Magnetic Resonance Imaging (MRI) Systems
14.2.3. Computed Tomography (CT) Scanner
14.2.4. Position emission tomography (PET) System
14.2.5. Ultrasound Imaging Systems
14.2.6. Others
14.3. Market Value Forecast By Indication, 2017 - 2031
14.3.1. Neurodegenerative Disease
14.3.2. Epilepsy
14.3.3. Stroke
14.3.4. Others
14.4. Market Value Forecast By End-user, 2017 - 2031
14.4.1. Hospitals and Surgery Centers
14.4.2. Neurology Centers
14.4.3. Ambulatory Care Centers
14.4.4. Diagnostic Laboratories & Imaging Centers
14.4.5. Research Laboratories & Academic Institutes
14.5. Market Value Forecast By Country, 2017 - 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Device Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Neurosoft
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Canon Medical Systems Corporation (Canon, Inc.)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Fujifilm Holding Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Koninklijke Philips N.V.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Siemens Healthineers AG
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Shimadzu Corporation
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. United Imaging Healthcare Co., Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Hologic, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Esaote SpA
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Device Type, 2017 - 2031
Table 02: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Indication, 2017 - 2031
Table 03: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 04: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017 - 2031
Table 05: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017 - 2031
Table 06: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Devices Type, 2017 - 2031
Table 07: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Indication, 2017 - 2031
Table 08: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 09: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031
Table 10: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Devices Type, 2017 - 2031
Table 11: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Indication, 2017 - 2031
Table 12: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 13: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031
Table 14: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Devices Type, 2017 - 2031
Table 15: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Indication, 2017 - 2031
Table 16: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 17: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031
Table 18: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Devices Type, 2017 - 2031
Table 19: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Indication, 2017 - 2031
Table 20: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 21: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031
Table 22: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Devices Type, 2017 - 2031
Table 23: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by Indication, 2017 - 2031
Table 24: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
List of Figures
Figure 01: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast, 2017 - 2031
Figure 02: Global Neurology Diagnostic and Monitoring Devices Market Value Share, by Region, 2022
Figure 03: Global Neurology Diagnostic and Monitoring Devices Market Value Share, by Indication, 2022
Figure 04: Global Neurology Diagnostic and Monitoring Devices Market Value Share, by Device Type, 2022
Figure 05: Global Neurology Diagnostic and Monitoring Devices Market Value Share, by End-user, 2022
Figure 06: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Device Type, 2022 - 2031
Figure 07: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by Device Type, 2022
Figure 08: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by Device Type, 2031
Figure 09: Global Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Device Type, 2023 - 2031
Figure 10: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Electroencephalogram (EEG) Systems, 2017 - 2031
Figure 11: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Electroencephalogram (EEG) Systems, 2022 - 2031
Figure 12: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Magnetic Resonance Imaging (MRI) Systems, 2017 - 2031
Figure 13: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Magnetic Resonance Imaging (MRI) Systems, 2022 - 2031
Figure 14: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Computed Tomography (CT) Scanner, 2017 - 2031
Figure 15: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Computed Tomography (CT) Scanner, 2022 - 2031
Figure 16: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Ultrasound Imaging Systems, 2017 - 2031
Figure 17: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Ultrasound Imaging Systems, 2022 - 2031
Figure 18: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Position emission tomography (PET) System, 2017 - 2031
Figure 19: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Position emission tomography (PET) System, 2022 - 2031
Figure 20: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Others, 2017 - 2031
Figure 21: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Others, 2022 - 2031
Figure 22: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Indication, 2022 - 2031
Figure 23: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by Indication, 2022
Figure 24: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by Indication, 2031
Figure 25: Global Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Indication, 2023 - 2031
Figure 26: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Neurodegenerative Disease, 2017 - 2031
Figure 27: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Neurodegenerative Disease, 2022 - 2031
Figure 28: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Epilepsy, 2017 - 2031
Figure 29: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Epilepsy, 2022 - 2031
Figure 30: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Stroke, 2017 - 2031
Figure 31: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Stroke, 2022 - 2031
Figure 32: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Others, 2017 - 2031
Figure 33: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Others, 2022 - 2031
Figure 34: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by End-user, 2022 - 2031
Figure 35: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by End-user, 2022
Figure 36: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by End-user, 2031
Figure 37: Global Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 38: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Hospitals and Surgery Centers, 2017 - 2031
Figure 39: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Hospitals and Surgery Centers, 2022 - 2031
Figure 40: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Neurology Centers, 2017 - 2031
Figure 41: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Neurology Centers, 2022 - 2031
Figure 42: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Ambulatory Care Centers, 2017 - 2031
Figure 43: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Ambulatory Care Centers, 2022 - 2031
Figure 44: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Diagnostic Laboratories & Imaging Centers, 2017 - 2031
Figure 45: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Diagnostic Laboratories & Imaging Centers, 2022 - 2031
Figure 46: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn), by Research Laboratories & Academic Institutes, 2017 - 2031
Figure 47: Global Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Research Laboratories & Academic Institutes, 2022 - 2031
Figure 48: Global Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Region, 2022 - 2031
Figure 49: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by Region, 2022
Figure 50: Global Neurology Diagnostic and Monitoring Devices Market Share Analysis, by Region, 2031
Figure 51: Global Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Region, 2023 - 2031
Figure 52: North America Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Country, 2022 - 2031
Figure 53: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017 - 2031
Figure 54: North America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Country, 2023 - 2031
Figure 55: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Devices Type, 2022 - 2031
Figure 56: North America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Devices Type, 2023 - 2031
Figure 57: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Indication, 2022 - 2031
Figure 58: North America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Indication, 2023 - 2031
Figure 59: North America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by End-user, 2022 - 2031
Figure 60: North America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 61: Europe Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Country, 2022 - 2031
Figure 62: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017 - 2031
Figure 63: Europe Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Country, 2023 - 2031
Figure 64: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Devices Type, 2022 - 2031
Figure 65: Europe Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Devices Type, 2023 - 2031
Figure 66: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Indication, 2022 - 2031
Figure 67: Europe Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Indication, 2023 - 2031
Figure 68: Europe Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by End-user, 2022 - 2031
Figure 69: Europe Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 70: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Country, 2022 - 2031
Figure 71: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017 - 2031
Figure 72: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Country, 2023 - 2031
Figure 73: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Devices Type, 2022 - 2031
Figure 74: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Devices Type, 2023 - 2031
Figure 75: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Indication, 2022 - 2031
Figure 76: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Indication, 2023 - 2031
Figure 77: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by End-user, 2022 - 2031
Figure 78: Asia Pacific Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 79: Latin America Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Country, 2022 - 2031
Figure 80: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017 - 2031
Figure 81: Latin America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Country, 2023 - 2031
Figure 82: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Devices Type, 2022 - 2031
Figure 83: Latin America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Devices Type, 2023 - 2031
Figure 84: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Indication, 2022 - 2031
Figure 85: Latin America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Indication, 2023 - 2031
Figure 86: Latin America Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by End-user, 2022 - 2031
Figure 87: Latin America Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 88: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value Share Analysis, by Country, 2022 - 2031
Figure 89: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017 - 2031
Figure 90: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Country, 2023 - 2031
Figure 91: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Devices Type, 2022 - 2031
Figure 92: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Devices Type, 2023 - 2031
Figure 93: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by Indication, 2022 - 2031
Figure 94: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by Indication, 2023 - 2031
Figure 95: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Value (US$ Mn) Share Analysis, by End-user, 2022 - 2031
Figure 96: Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Neurology Diagnostic and Monitoring Devices Market
